Jimk7

China Biotech Week in Review: East-West Interdependence in 2007

A lot of U.S. bio-pharma companies are taking stakes in established entities listed on the Hong Kong exchange. Though we probably won't see pops like we would in Chinese companies listed in the U.S. It could be something to gamble on for the long-term. You can pick them up for pennies on the dollar per share but most of the time are required to buy in blocks of thousands.